H. Glantschnig et al., THE CELLULAR PROTOONCOGENES C-FOS AND EGR-1 ARE REGULATED BY PROSTACYCLIN IN RODENT OSTEOBLASTS AND FIBROBLASTS, Endocrinology, 137(11), 1996, pp. 4536-4541
PGs are local regulators of various cellular functions. They exert the
ir effects via specific PG receptor subtypes. Induction of c-fos gene
expression has been described for arachidonic acid and its metabolite
PGE(2). We demonstrate that another very short half-lifed prostanoid m
etabolite, namely prostacyclin (PGI(2)), is a regulator of immediate-e
arly genes. PGI(2) transiently induced the growth-associated immediate
-early genes c-fos and egr-1 in osteoblastic as well as fibroblastic c
ell lines. Furthermore, we showed that PGI(2) dose dependently stimula
ted new DNA synthesis in the osteoblastic cell line MC3T3-E1. Although
PGI(2) is known to be a potent inducer of cyclooxygenases, we showed
that this pathway is not necessary for protooncogene induction by PGI(
2). Our data indicate a direct effect of PGI(2) on immediate-early gen
e expression, which does not depend on the synthesis of other prostano
ids. Intracellular signal transduction mechanisms were studied with th
e protein kinase inhibitor H-7, a potent inhibitor of PGI(2)-induced c
-fos expression. Experiments with phorbol esters revealed that protein
kinase C activity is not obligatory for the effect of PGI(2) on c-fos
expression. We conclude from these results that PGI(2), a rapidly ina
ctivated prostanoid, has a major impact on cellular oncogene expressio
n and growth in mesenchymally derived cells.